NCT04757051 is a clinical trial in Knee Osteoarthritis, sponsored by TRB Chemedica AG.

Who is sponsoring NCT04757051?

NCT04757051 is sponsored by TRB Chemedica AG.

What condition does NCT04757051 study?

NCT04757051 studies Knee Osteoarthritis.

Is NCT04757051 still recruiting?

NCT04757051 is currently completed. Last updated 3 August 2022.

Last reviewed 2022-08-03 · How we verify

NCT04757051

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Real-life Use of BENART TM in Patients With Symptomatic Knee Osteoarthritis

Completed Last updated 3 August 2022

What this trial tests

trial in Knee Osteoarthritis in 50 participants. Completed in 25 April 2022.

Timeline

11 March 2021

Primary endpoint
25 April 2022

25 April 2022

Quick facts

Lead sponsor	TRB Chemedica AG
Status	Completed
Study type	OBSERVATIONAL
Enrollment	50
Start date	11 March 2021
Primary completion	25 April 2022
Estimated completion	25 April 2022
Sites	1 location across Germany

Conditions studied

Knee Osteoarthritis — all drugs for Knee Osteoarthritis →

Sponsor

TRB Chemedica AG

Who can join

18 and older, any sex, with Knee Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

PMCF study to assess the effectiveness and safety of BENART in the treatment of symptomatic knee OA in a real-life clinical setting when used according to the instructions for use.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Long-Term Efficacy Following Intra-articular Injection of Carboxymethyl-chitosan, a New Product Class for Knee Osteoarthritis: Results from an Observational Study in Germany.
Lynen NA, Eichhorn C, Portelange N, Chausson M, et al · · 2024 · cited 7× · PMID 38498142 · DOI 10.1007/s40744-024-00661-6

Verify or expand the search:

Other recruiting trials for Knee Osteoarthritis

Currently open trials in the same condition.

NCT06906939 — A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression · EARLY_PHASE1 · recruiting
NCT05823727 — Effects of Collagen Peptide Supplementation on Connective Tissue Remodeling, Functional Outcomes, and Wound Healing Afte · NA · recruiting
NCT07370480 — Knee Osteoarthritis and Thermal Spa Treatment · NA · recruiting
NCT07507175 — Gastrocnemius Myofascial Release in Females With Knee Osteoarthritis · NA · recruiting
NCT07386600 — Dexamethasone vs Dexmedetomidine for iPACK + ACB in TKA · NA · recruiting

Other TRB Chemedica AG trials

Trials by the same sponsor.

NCT03879434 — Routine Application of Ostenil® Mini in Patients with Rhizarthrosis · completed
NCT03809962 — Efficacy and Safety of Ostenil® Plus in the Treatment of Coxarthrosis · completed
NCT03734315 — Routine Application of Ostenil® in Patients with Gonarthrosis · completed
NCT03494140 — Viscontour® Serum Med in Hydration of Facial Skin · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04757051 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by TRB Chemedica AG
Last refreshed: 3 August 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04757051.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing